Antioxidant status in thyroid dysfunction

Clinical Chemistry and Laboratory Medicine

Volumn 40, Issue 11, 2002, Pages 1132-1134

  Resch, Ulrike ^a   Helsel, Gwen ^b   Tatzber, Franz ^a   Sinzinger, Helmut ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF THE PACIFIC   (United States)

Author keywords

Antioxidant status; Atherosclerosis; Thyroid hormones

Indexed keywords

ANTIOXIDANT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THYROID ANTIBODY; THYROID PEROXIDASE; THYROTROPIN;

ADULT; ANTIBODY TITER; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME BLOOD LEVEL; EUTHYROIDISM; HUMAN; HYPERMETABOLISM; HYPERTHYROIDISM; HYPOTHYROIDISM; OXIDATIVE STRESS; PRIORITY JOURNAL; THYROTROPIN BLOOD LEVEL;

ADULT; ANTIBODIES; ANTIOXIDANTS; CHOLESTEROL; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; LIPID PEROXIDES; LIPOPROTEINS, LDL; MIDDLE AGED; OXIDATIVE STRESS; THYROID HORMONES;

EID: 0346668235     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2002.198     Document Type: Article

References (12)

1. Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Annal Intern Med 2000; 132:270-8.
2. Epstein FH. Thyroid hormone and the cardiovascular system. N Engl J Med 2001; 344:501-9.
3. Esterbauer H, Schmidt R, Hayn M. Relationships among oxidation of low-density lipoprotein, antioxidant protection, and atherosclerosis. In: Sies H, editor. Advances in pharmacology: antioxidants in disease mechanisms and therapy. London: Academic Press Inc. 1997; 38:425-55.
4. Navab M, Fogelman AM, Berliner JA, Territo MC, Demer LL, Frank JS, et al. Pathogenesis of atherosclerosis. Am J Cardiol 1995; 76:18-32C.
5. Esterbauer H, Gebicki J, Puhl H, Jürgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Rad Biol Med 1992; 13:341-90.
6. Asayama FK, Kato K. Oxidative muscular injury and its relevance to hyperthyroidism. Free Rad Biol Med 1990; 8:293-303.
7. Sacks FM, Alaupovic P, Moye LA, Cole TG, Sussex B, Stampfer MJ, et al. VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial. Circulation 2000; 102:1886-92.
8. Tatzber F, Griebenow S, Wonisch W, Winkler R. Dual methods for total peroxide and peroxidase-activity determination-iodide proofed to enhance peroxidase-activity in human sera. Anal Biochem (Submitted).
9. Salonen JT, Yla-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, et al. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 1992; 339:883-7.
10. Palinski W, Tangirala RK, Miller E, Young SG, Witztum JL. Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis. Arterioscler Thromb Vasc Biol 11995, 15:1569-76.
11. Witztum JL, Palinski W. Are immunological mechanisms relevant for the development of atherosclerosis? Clin Immunol 1999; 90:153-6.
12. Palinski W, Witztum JL. Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis. J Intern Med 2000; 247:371-80.